Abstract
New York-Presbyterian Hospital and Columbia University Irving Medical Center were heavily impacted by the COVID-19 pandemic. Various measures were taken in an effort to ensure patient and staff safety. The management of patients with complex dermatological oncologic conditions, such as cutaneous T-cell lymphoma (CTCL) was especially challenging. We present a case review of patients diagnosed with CTCL who also had confirmed or suspected COVID-19 infection (n = 6). Diagnoses included were mycosis fungoides (n = 2), Sézary syndrome (n = 2), and primary cutaneous CD30+ lymphoproliferative disorder (n = 2).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
